Avidity Biosciences Income from Continuous Operations 2019-2025 | RNA
Avidity Biosciences income from continuous operations for the twelve months ending June 30, 2025 was $-0.456B, a 80.53% increase year-over-year.
- Avidity Biosciences annual income from continuous operations for 2024 was $-0.322B, a 51.87% increase from 2023.
- Avidity Biosciences annual income from continuous operations for 2023 was $-0.212B, a 21.97% increase from 2022.
- Avidity Biosciences annual income from continuous operations for 2022 was $-0.174B, a 47.44% increase from 2021.